Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Division of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, China.
Ann Rheum Dis. 2019 Oct;78(10):1388-1397. doi: 10.1136/annrheumdis-2019-215567. Epub 2019 Jul 17.
Previous work has revealed a genetic association between Takayasu arteritis and a non-coding genetic variant in an enhancer region within (rs2069837 A/G). The risk allele in this variant (allele A) has a protective effect against chronic viral infection and cancer. The goal of this study was to characterise the functional consequences of this disease-associated risk locus.
A combination of experimental and bioinformatics tools were used to mechanistically understand the effects of the disease-associated genetic locus in . These included electrophoretic mobility shift assay, DNA affinity precipitation assays followed by mass spectrometry and western blotting, luciferase reporter assays and chromosome conformation capture (3C) to identify chromatin looping in the locus. Both cell lines and peripheral blood primary monocyte-derived macrophages were used.
We identified the monocyte/macrophage anti-inflammatory gene ,~520 kb from , as a target gene regulated by rs2069837. We revealed preferential recruitment of myocyte enhancer factor 2-histone deacetylase (MEF2-HDAC) repressive complex to the Takayasu arteritis risk allele. Further, we demonstrated suppression of GPNMB expression in monocyte-derived macrophages from healthy individuals with AA compared with AG genotype, which was reversed by histone deacetylase inhibition. Our data show that the risk allele in rs2069837 represses the expression of GPNMB by recruiting MEF2-HDAC complex, enabled through a long-range intrachromatin looping. Suppression of this anti-inflammatory gene might mediate increased susceptibility in Takayasu arteritis and enhance protective immune responses in chronic infection and cancer.
Takayasu arteritis risk locus in might increase disease susceptibility by suppression of the anti-inflammatory gene through chromatin looping and recruitment of MEF2-HDAC epigenetic repressive complex. Our data highlight long-range chromatin interactions in functional genomic and epigenomic studies in autoimmunity.
先前的研究揭示了大动脉炎与增强子区域内非编码遗传变异(rs2069837A/G)之间的遗传关联。该变异中的风险等位基因(等位基因 A)对慢性病毒感染和癌症具有保护作用。本研究的目的是描述该疾病相关风险位点的功能后果。
采用实验和生物信息学工具相结合的方法,从机制上理解与疾病相关的遗传位点在中的作用。这些方法包括电泳迁移率变动分析、DNA 亲和力沉淀测定结合质谱和 Western blot、荧光素酶报告基因测定和染色质构象捕获(3C),以鉴定中染色质环。使用细胞系和外周血原代单核细胞衍生的巨噬细胞。
我们确定了单核细胞/巨噬细胞抗炎基因~520kb 来自于 rs2069837 调控的基因。我们发现,肌细胞增强因子 2-组蛋白去乙酰化酶(MEF2-HDAC)抑制复合物优先募集到大动脉炎风险等位基因。此外,我们发现在 AA 基因型的健康个体的单核细胞衍生的巨噬细胞中,与 AG 基因型相比,GPNMB 的表达受到抑制,而组蛋白去乙酰化酶抑制可逆转这种抑制。我们的数据表明,rs2069837 中的风险等位基因通过募集 MEF2-HDAC 复合物抑制 GPNMB 的表达,这是通过长程染色质内环实现的。这种抗炎基因的抑制可能介导了大动脉炎的易感性增加,并增强了慢性感染和癌症中的保护性免疫反应。
位于中的大动脉炎风险位点可能通过染色质环和 MEF2-HDAC 表观遗传抑制复合物的募集,抑制抗炎基因的表达,从而增加疾病易感性。我们的数据强调了在自身免疫功能基因组和表观基因组研究中的长程染色质相互作用。